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ABSTRACT 
HYDRODYNAMIC EFFECTS OF A CANNULA 
IN A USP DISSOLUTION TESTING APPARATUS 2 
 
by 
Qianqian Liu 
Dissolution testing is routinely used in the pharmaceutical industry to provide in vitro 
drug release information for drug development and quality control purposes. The USP 
Testing Apparatus 2 is the most common dissolution testing system for solid dosage 
forms. Usually, sampling cannulas are used to take samples manually from the 
dissolution medium. However, the inserted cannula can alter the normal fluid flow within 
the vessel and produce different dissolution testing results. 
The hydrodynamic effects introduced by a permanently inserted cannula in a USP 
Dissolution Testing Apparatus 2 were evaluated by two approaches.  Firstly, the 
dissolution tests were conducted with two dissolution systems, the testing system (with 
cannula) and the standard system (without cannula), for nine different tablet positions 
using non-disintegrating salicylic acid calibrator tablets. The dissolution profiles at each 
tablet location in the two systems were compared using statistical tools. Secondly, 
Particle Image Velocimetry (PIV) was used to obtain experimentally velocity vector 
maps and velocity profiles in the vessel for the two systems and to quantify changes in 
the velocities on selected horizontal iso-surfaces. 
The results show that the system with the cannula produced higher dissolution 
profiles than that without the cannula and that the magnitude of the difference between 
dissolution profiles in the two systems depended on tablet location.  However, in most 
dissolution tests, the changes in dissolution profile due to the cannula were small enough 
to satisfy the FDA criteria for similarity between dissolution profiles (f1 and f2 values). 
 
 
PIV measurements showed slightly changes in the velocities of the fluid flow in 
the vessel where the cannula was inserted.  The most significant velocity changes were 
observed closest to the cannula.  However, generally the hydrodynamic effect generated 
by the cannula did not appear to be particularly strong, which was consistent to 
dissolution test results. 
It can be concluded that the hydrodynamic effects generated by the inserted 
cannula are real and observable.  Such effects result in slightly modifications of the fluid 
flow in the dissolution vessel and in detectable differences in the dissolution profiles, 
which, although limited, can introduce variations in test results possibly leading to failure 
of routine dissolution tests. 
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CHAPTER 1     
INTRODUCTION 
1.1 Background 
In the pharmaceutical industry, dissolution testing is routinely used to simulate adequate 
in vivo drug release of oral solid dosage forms through in vivo/in vitro correlations 
(IVIVC), as required by the Food and Drug Administration (FDA) and specified in 
United States pharmacopoeia (USP). Dissolution testing has emerged as an essential tool 
to guide and assess the design of new formulations, and as a quality control technique to 
monitor lot-to-lot consistency of the drug products.  
The USP Dissolution Testing Apparatus 2 is the most commonly and widely used 
of all the dissolution testing devices listed in the USP (2012). It has been used in 
pharmaceutical industry for decades since it was first officially introduced as a USP 
method in the 1970s (Cohen et al., 1990). However, a review of the literature shows that 
it is susceptible to errors and test failures (Cox and Furman, 1982; Cox et al., 1983; 
Bocanegra et al., 1990; Moore et al., 1995; Qureshi and McGilveray, 1999; Qureshi and 
Shabnam, 2001; Mauger et al., 2003), possibly associated to the extreme susceptibility of 
this apparatus to small variation in its geometry and the location of the tablet during the 
dissolution process (Bai and Armenante, 2009).  
In recent years, a number of investigations have been conducted to determine the 
hydrodynamics of the dissolution apparatus. Both experimental and computational 
methods have been used, such as Laser Doppler Velocimetry (LDV), Particle Image 
Velocimetry (PIV), Laser-Induced Fluorescence (LIF), and Computational Fluid 
Dynamics (CFD) (Bocanegra et al., 1990; McCarthy et al., 2003, 2004; Kukura et al., 
2 
2003, 2004; Baxter et al., 2005; Bai et al., 2007, 2011; Bai and Armenante, 2008, 2009). 
These studies have indicated that the hydrodynamics of USP Dissolution Testing 
Apparatus 2 can be responsible for some of the poor reproducibility and inconsistencies 
of the dissolution results since the fluid flow in Apparatus 2 is highly nonhomogeneous. 
This system can be expected to be associated with a complex hydrodynamics, resulting in 
fluid velocities whose directions and intensities are highly dependent on the location 
within the vessel, especially at the bottom of the vessel where the tablet is usually located 
during dissolution testing (Bai et al., 2011).  
Another source of variability during dissolution testing is associated with small 
changes in the geometry of the system due to the fact that USP Apparatus 2 consists of a 
symmetrical vessel with no baffles (Wang and Armenante, 2012). For example, a slightly 
irregular inner shape of a glass dissolution vessel can produce very different dissolution 
profiles that may result in test failures (Tanaka et al., 2005; Liddell et al., 2007). Also, 
Bai and Armenante (2008) reported significant changes in velocity profiles and shear 
rates when impeller location was placed 2 mm off center within the vessel through 
Computational Fluid Dynamics (CFD) approach. Such small geometry changes can be 
expected to affect the dissolution profile of a tablet located at the bottom of the vessel, 
and were confirmed by Wang and Armenante (2012) using an experimental approach 
(placing the paddle 8 mm off vessel’s center). External vibrations have also been shown 
to introduce significant variability in the dissolution profiles (Gao et al., 2006; 2008).  
Similarly, a sampling probe permanently inserted in the dissolution medium can 
also changes the symmetry of the dissolution system and the hydrodynamics within the 
vessel, hence possibly affecting the dissolution profile of the tablet (Wells, 1981; Savage 
3 
and Wells, 1982; Schatz et al., 2000; Bynum et al., 2001; Lu et al., 2003; Nie et al., 
2009). Even if the size of the sampling probe is small, it can still act as a small baffle in a 
perfectly symmetrical system. The resulting loss of symmetry and the introduction of a 
baffling effect can result in changes in velocity profile and shear rates, which in turn 
could cause variations in dissolution testing results comparing to the system without such 
a device (Wells, 1981; Savage and Wells, 1982; Cox et al., 1984).  
Cannulas are among the simplest and most common sampling probes used in 
Apparatus 2. A cannula consists of a thin tube attached to a syringe and used to take 
samples from the dissolution medium manually. Cannulas vary in length from 4.75” (120 
mm) to 15” (380 mm) and are made from either stainless steel or plastic materials such as 
polyether ether ketone (PEEK) in order to prevent adsorption or interference with the 
active ingredient of the drug. A cannula is usually mounted on perforated stopper that is 
inserted in the vessel lid during manual sampling (to ensure that the sample is always 
taken at the same liquid depth) and then rapidly removed after the sample is collected.  
Sometimes a filter is mounted at the end of the sampling cannula. Although manual 
sampling is labor intensiveness and susceptibility to operator’s error, it is still widely 
used in pharmaceutical industry and auto-sampling requires validation with manual 
sampling (USP 2012). 
In order to simplify sample collection or to automate the sampling process, a 
cannula can be permanently inserted in the medium in the dissolution vessel.  In such a 
case, the cannula can act as a small baffle and affect the system hydrodynamics and the 
dissolution rate just like any other probe, as already mentioned above. Investigations 
about the effect of sampling probes have been conducted in the past. Early studies by 
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Wells (1981) and Savage and Wells (1982) pointed out that the use of sampling probes, 
especially those larger in size, could result in appreciably faster dissolution rates than the 
results obtained from the system absence of a fixed probe. Cox et al. (1984) 
recommended using small cannulas without a filter mounted at the end to reduce 
hydrodynamics effects. Other investigators have instead concluded that the presence of a 
probe had a minimal or small effect on dissolution (Lu et al., 2003; Mirza et al., 2009; 
Nie et al., 2009). However, in most of those studies the effect of an auto-sampling probe, 
such as a fiber optic probe, was investigated.  Recently, two studies on the effect of the 
presence of a fiber optic sampling probe on dissolution have been conducted by our 
group (Zhang et al, 2013; Wang et al., 2013). These studies have shown that even such a 
probe can alter the system’s hydrodynamics significantly enough to result in small but 
statistically differences in dissolution profiles. However, and except as noted above, no 
well-defined, detailed studies with Apparatus 2 dissolution systems have been conducted 
in which a cannula is permanently inserted in the medium.   
1.2 Objectives of This Work 
The overall objective of this research work was to quantify the hydrodynamic effects of a 
cannula in a USP Dissolution Testing Apparatus 2. This goal was achieved here by using 
two different methodologies, i.e., dissolution tests using non-disintegrating tablets 
(salicylic acid calibrator tablets) and velocity measurements using Particle Image 
Velocimetry (PIV). 
In order to study solely the hydrodynamic changes introduced by the cannula and 
its effect on the dissolution profiles, any other factors that could also affect the test results 
should be eliminated. As shown in previous studies (Bai et al., 2009; Wang and 
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Armenante, 2012) on the USP Dissolution Apparatus 2, tablets placed at different 
locations of the vessel’s bottom produced significant variations in flow velocities and 
dissolution profiles. Therefore, in this study dissolution tests were conducted in the 
presence and in the absence of the cannula using not only tablets dropped in the vessel as 
recommended by the USP, but also using tablets fixed in place at 9 different positions at 
the bottom of the USP Apparatus 2 dissolution vessels. Statistical tools, such as f1, f2 
factor and Student’s t-values, were used to evaluate and compare the results from two 
systems at the same tablet location. 
Additionally, PIV studies were conducted in order to find the root cause of the 
possible hydrodynamic effects introduced by the cannula on the dissolution profiles. PIV 
was used to visualize and quantify the flow velocity field in the dissolution vessel under 
different conditions. Then a comparison of the variations in flow field between the testing 
system (with the cannula) and the standard system (without the cannula) was performed. 
This approach also allowed a comparison to be made between changes in the dissolution 
profiles and variations in the flow filed that could be attributed to the presence or absence 
of the cannula. 
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CHAPTER 2  
EXPERIMENTAL APPARATUS, MATERIALS AND METHODS 
2.1 Dissolution Tests 
2.1.1 Dissolution Apparatus 
A commercial USP Dissolution Testing Apparatus 2 (Distek 5100 Bathless Dissolution 
Apparatus; Distek Inc., North Brunswick, NJ), as shown in Figure 2.1a, was used to 
conduct all dissolution experiments. This equipment can accommodate seven standard 
dissolution vessels consisting of unbaffled, cylindrical, hemisphere-bottomed transparent 
glass vessels. Each vessel is provided with a lid with two openings for sampling during in 
the experiments (Figure 2.1b). The agitation system consisted of a standard USP 
Apparatus 2 two-paddle impeller mounted on a shaft and connected to the motor in the 
Distek system rotating at 100 rpm.  
              
(a)       (b) 
Figure 2.1 (a) Distek 5100 Bathless Dissolution Apparatus (b) USP Dissolution Testing 
Apparatus 2: paddle impeller and glass vessel. 
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The exact geometric dimensions of the impeller were measured with a caliper, 
and were found to be as follows: shaft diameter, 9.52 mm; length of the top edge of the 
blade, 74.10 mm; length of the bottom edge of the blade, 42.00 mm; height of the blade, 
19.00 mm; and thickness of the blade, 4.00 mm. The impeller clearance off the vessel 
bottom was 25 mm, as prescribed by the USP (2012). When the vessel was filled with 
900 mL of dissolution media, the corresponding liquid height was 132.43 mm, measured 
from the bottom of the vessel. The geometry of the system (vessel with 900 mL of 
dissolution media and agitation system) is shown in Figure 2.2. 
The cannula tested in this study was a bent polyether ether ketone (PEEK) 
cannula purchased from Hanson. The cannula was 210 mm in length (from head mount to 
the tail-end) with a 160-mm straight section and a 3.14-mm OD, as measured by the 
caliper. As specified in the USP, samples, when taken with a cannula, should be taken 
within a required zone in the dissolution medium, i.e., vertically midway between the top 
edge of the impeller and the surface of the dissolution medium, and horizontally located 
not less than 1 cm from the vessel wall. A stopper was used to ensure that the bottom of 
the cannula was located in the sampling zone during dissolution tests, although here the 
cannula was not used for manual sampling.  The cannula with the stopper is shown in 
Figure 2.3 and the detailed position of the cannula in the vessel is shown in Figure 2.4. 
A spectrophotometer (Cole Parmer S2100UV+) was used to analyze the liquid 
samples and get the UV absorption data. 
A pH meter (Hanna Instruments HI221) was used to adjust the pH value of the 
dissolution medium to 7.4 ± 0.05. 
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Figure 2.2 (a) Front view of USP Dissolution Testing Apparatus 2 vessel. 
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Figure 2.2 (b) Bottom view of USP Dissolution Testing Apparatus 2 vessel (Continued). 
 
Figure 2.3 The cannula with the stopper. 
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Figure 2.4 (a) Front view the dissolution testing vessel with the cannula. 
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Figure 2.4 (b) Side view of the dissolution testing vessel with the cannula. 
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Figure 2.4 (c) Top view of the dissolution testing vessel with the cannula. 
 
2.1.2 Dissolution Test Materials 
Non-disintegrating tablets, i.e., 300 mg salicylic acid calibrator tablets (USP lot 
Q0D200), purchased from USP (Rockville, MD) were used in the dissolution testing 
experiments. A very small amount of commercial acrylic glue was used to fix the tablet at 
a particular position on the bottom of the dissolution vessel. 
900 mL of de-aerated phosphate buffer constituted the dissolution medium. The 
medium consisted of a 0.05 M monobasic potassium phosphate buffer to which sodium 
hydroxide was added to reach a final pH value of 7.4 ± 0.05. The medium was de-aerated 
before using it according to the degassing method developed by Moore (1996) following 
the USP requirement (USP, 2012) (Figure 2.5). Accordingly, the medium was placed in a 
carboy tank connected to a vacuum pump. Vacuum was applied for 30 minutes while all 
other valves in the system were closed. This stock solution was used as needed (typically 
in 900 mL aliquots per test).  
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Figure 2.5 Setup of de-aeration process for dissolution medium. (USP, 2008) 
 
In this work, two 12 mL syringes and two stainless steel cannulas (2 mm OD) 
were used to take samples manually from the dissolution systems. Disposable PVDF 0.45 
µm filters were attached to the syringes to remove possible solid particles that could have 
entered the liquid samples, as described in Section 2.1.3. 
2.1.3 Dissolution Test Method 
Each side-by-side experiment consisted of conducting dissolution tests in both the system 
with the permanently inserted cannula and in the standard dissolution system without the 
cannula. The agitation speed was always 100 rpm and the temperature was maintained at 
37 oC throughout the dissolution experiment by the system’s temperature controller. Each 
dissolution test for any tablet configuration was performed in triplicate. 
Two approaches were used to expose the tablet to the dissolution medium during 
the dissolution test. The first was the approach specified in the USP (2012). Accordingly, 
the tablet was dropped in the vessel at the beginning of the experiment, the agitation (100 
rpm) was started, and the first manual sample was immediately collected. 
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The second approach was slightly different from that recommended by the USP in 
that the tablets were glued at the same predefined location on the vessel bottom in both 
systems with a very small head of commercial glue prior to the beginning of the 
experiment. Nine tablet positions were investigated in the non-symmetrical testing 
system with the cannula, as shown in Figure 2.6(a). Tablets in Position O were placed in 
the center of the vessel bottom. Positions A1, B1, C1 and D1 were all on the same inner 
circle 10° off-center from the vessel vertical centerline while Position A2, B2, C2 and D2 
were all on the same outer circle 20° off-center from the vessel vertical centerline (Figure 
2.6(b)). These angles originated from the center of the sphere comprising the 
hemispherical vessel bottom, and were measured starting from the vertical centerline to 
the point of interest, (e.g., the angle would be zero for the central point below the 
impeller). On each circle, the positions were spaced 90° apart from each other.  In the 
standard system, the same nine tablet positions were selected in order to make pairs with 
that from the testing system, although only three positions would be sufficient in the 
symmetrical standard system.  
  
Figure 2.6 (a) Top view of the bottom of the dissolution vessel with nine different tablet 
positions in testing system. 
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(b) 
Figure 2.6 (b) The front view of the dissolution vessel with three different tablet 
positions (0°, 10°, 20°) in standard system (Continued).  
 
All key geometrical measurements were checked before each experiment 
(impeller clearance, impeller position, etc.). Once the vessels with the attached tablets 
were setup properly in the Distek system, 900 mL de-aerated dissolution medium, 
previously preheated to 37.5 oC, was gently poured into each of the two vessels in order 
to minimize gas introduction and prevent the rapid initial dissolution of the tablet. The 
agitation was turned on immediately after the addition of the dissolution medium, the 
cannula was inserted to the predefined place in the testing system, and a stopwatch was 
started simultaneously.   
Sample collection was always manual (i.e., it did not rely on the use of the 
cannula) and was identical for all experiments. The first pair of samples was taken 
immediately after starting the agitation. These samples concentrations were defined as the 
zero-time-point concentration. The time interval between subsequent samples was 5 
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minutes. Each experiment lasted 45 min, which meant that ten samples were taken for 
each system.    
Each 10-mL aliquot sample was taken manually from the dissolution medium 
using a 12-mL syringe and a stainless steel cannula (2 mm OD). The volume of medium 
removed by sampling was not replaced, according to the USP procedure (USP, 2012). 
The sampling position was vertically midway between the top edge of the impeller and 
the surface of the dissolution medium and horizontally located 13.22 mm from the vessel 
wall, that is, within the USP specified sampling zone. After the sample was collected, the 
stainless steel cannula was removed immediately and then a disposable PVDF 0.45 µm 
filter was mounted on the syringe to remove possible solid particles that could have 
entered the sample prior the sample analysis. The initial 2 mL of each sample was 
discarded, and the remaining sample was transferred to a vial for further analysis.  
Analysis of samples was carried out using 1-cm quartz cell placed in a UV 
spectrophotometer (Cole Parmer S2100UV+; Cole Parmer, Vernon Hills, Illinois) 
measuring absorbance at 296 nm, the USP prescribed wavelength for salicylic acid. 
Before putting the sample solution into the quartz cell to analyze, the cell was rinsed 
three times with the same solution. The absorbance reading were converted to the 
concentration of dissolved salicylic acid using a previously obtained absorbance-vs.-
concentration calibration curve (R2=0.9998). This calibration curve was obtained by 
preparing reference standard solutions of salicylic acid and diluting them to obtain 
solutions of different known concentrations. The absorbance of these solutions generated 
an absorbance versus concentration standard curve.  
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Note that for the salicylic acid tablet, for most experiments, samples collected 
after t=25 minutes needed to be diluted so that their UV absorbance was in the 
appropriate range.  These samples were diluted into one-half with dissolution medium. 
Additional details of the operating conditions are summarized in Table 2.1.   
Table 2.1 Operating Conditions for Dissolution Experiments with Calibrated Salicylic 
Acid Tablet 
Salicylic Acid Tablet Operating Conditions 
Dose 300 mg 
Medium 900 ml de-aerated, pH=7.4 buffer (KH2PO4) 
Temperature 37 oC 
Agitation Speed 100 rpm 
Filter PVDF 0.45 µm 
UV Wavelength (UV Spectroscopy) 296 nm 
Time 5 min sampling interval; 45 min total 
Sample Volume 10 ml 
Sample Replacement  No 
 
2.1.4 Dissolution Test Data Analysis 
The dissolution profiles are presented in terms of drug release fraction (mD/mT), that is, 
the mass of released drug in the dissolution medium at any time t out of the total mass of 
drug initially in the tablet, as a function of time. The absorbance data obtained from the 
UV spectrophotometer was first converted to salicylic acid concentration at given time, 
(Cj, in mg/mL), and then transformed into drug mass release fraction (mD/mT) using the 
following equations, in order to account for the drug mass removed with each sample:   
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where j is an index identifying the number of sampling (j=1, 2, … 10), mD(tj) is the mass 
of released salicylic acid at time tj, mT is the total mass of salicylic acid initially in the 
tablet, Cj is the dissolved salicylic acid concentration in the jth sampling at time tj, C* is 
the concentration of salicylic acid when the tablet is fully dissolved in 900 mL dissolution 
medium, ΔV is each sampling volume (10 mL) and V is the initial volume of dissolution 
medium (900 mL). At the beginning of the experiment (t=t1=0 minutes) the first sample 
was taken immediately (j=1) resulting in an initial concentration C1, and the 10th sample 
was taken at t10=45 minutes (j=10).  
The dissolution profiles obtained with tablets at each position in the testing 
system were compared to those from its paired standard system in order to determine 
whether these dissolution curves were statistically similar or not.  Two approaches were 
used.  The first approach was that recommended by the FDA to quantify the 
similarity/difference of two dissolution profiles. This approach consists of a model-
independent method based on the difference factor (f1) and similarity factor (f2) proposed 
by Moore and Flanner (1996):  
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where Rt is the reference assay at time t (i.e., the results from the standard system), Τt is 
the test assay at the same time (i.e., the paired results from the testing system), and n is 
the number of time points. The difference factor (f1) calculates the percent (%) difference 
between the two curves at each time point and measures the relative error between two 
curves. The higher the f1 (which can be in the range of 0 to 100), the higher the average 
difference between reference and test curves is (Moore and Flanner, 1996). The similarity 
factor (f2) is a logarithmic reciprocal square root transformation of the sum-squared error 
of differences between the reference and test profiles over all time points (which can be 
in the range -α to 100).  The higher the f2, the lower the average difference between 
reference and test curves is (Costa and Lobo, 2001). Public standards have been set by 
FDA for f1 and f2 factors. Accordingly, statistical similarity between the two curves being 
compared requires that 0<f1<15 or 50<f2<100 (FDA, 1997). 
The second approach was the standard Student’s t-test based on the analysis of 
variance and the calculation of the probability that the two sets of data came from the 
same underlying population (null hypothesis) using the following equations (Lapin, 
1975): 
µ−
= 0-
'
D
D
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S n
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= −' 1DF n   
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where 𝑋𝐷���� is the sample mean (here is the average differences between two curves), 𝜇0 is 
the population mean (in this case the constant from which to test whether the average of 
the difference is different, i.e., 𝜇0=0 here), SD is the sample standard deviation (here is the 
standard deviation of the differences between curves), DF is the degree of freedom (here 
the initial data point at t=0 was not used) and n’ is the number of samples excluding the 
first one (Schatz et al., 2001).  The probability that the null hypothesis is correct can be 
obtained from the T-value in Equation (2.5) using the experimental data as input and with 
the table of values from Student's t-distribution (Lapin, 1975).  The significance level was 
chosen here to be 0.05, i.e., if the probability obtained was smaller than 0.05, the null 
hypothesis was rejected and the two groups of data were considered to be statistically 
different. 
2.2 Particle Image Velocimetry (PIV) 
2.2.1 Particle Image Velocimetry (PIV) System 
A Dantec FlowMap 1500 2D Particle Image Velocimetry (PIV) apparatus (Dantec 
Dynamics A/S, Tonsbakken 16 – 18, DK – 2740 Skovlunde, Denmark) was used to 
determine the velocity flow field and turbulence intensity inside the dissolution vessel in 
both testing system and standard system. The PIV system comprised a double pulsed 120 
mJ Nd-Yag laser (New Wave Research model Solo 120 15 Hz, Fremont, CA, USA), a 
digital camera (Dantec Dynamics HiSense PIV/PLIF camera model C4742-53-12NRB) 
with a charge coupled device (CCD) chip, a synchronizer (LASERPULSE Synchronizer, 
TSI model 610034) and the software (FlowManager 4.71) installed in a computer (DELL 
Precision WorkStation 530), as shown in Figure 2.7.  
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Figure 2.7 Schematic of laboratory PIV experimental set-up. 
 
In the PIV experiment, the dissolution vessel was placed in an external Plexiglas 
square tank filled with water in order to minimize refractive effects at the curved surface 
of the vessel wall. Black plastic shaft and impeller were specially used to minimize the 
reflection of the laser light impinging on them. The agitation was kept 100 rpm and 
provided by an electric motor connected to an external controller. The water (900 mL) in 
the dissolution vessel was seeded with trace amounts of 10 μm silver-coated hollow 
borosilicate glass spheres (Dantec Measurement Technology USA, Mahwah, NJ, USA) 
which were used to follow the fluid flow and scatter the laser light for fluid velocity 
measurements. 
The light source of the PIV system came from the Class IV Nd-Yag laser, 
consisting of two infrared laser heads combined in a single package with a second 
harmonic generator and two discrete power supplies and emitting 532 nm wavelengths 
light. Two pulsed infrared laser beams were produced by the laser and passed through an 
optical arrangement of lenses to generate a laser light sheet. When the laser light sheet 
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was shot through the dissolution vessel with seed particles in the water, the light scattered 
by these particles was captured by the CCD camera which was installed next to the tank 
at a 90º orientation with respect to the laser light sheet.  A light filter is fitted in front of 
the camera lens to remove visible light and any incident laser light from reflection. The 
camera and the laser were connected to the synchronizer which was then in turn 
connected to the computer running the FlowManager 4.71 software for test control and 
data analysis. Pairs of digitized images of illuminated particles in the dissolution vessel 
from the camera were subdivided into small subsections called interrogation areas via the 
software and then were analyzed using cross-correlation to determine the spatial x- and y-
displacement that maximized the cross-correlation function for that interrogation area. 
The resulting displacement vector obtained by dividing the x- and y- displacements by 
the time interval was taken as the fluid velocity in that interrogation area.  
2.2.2 PIV Method 
In the PIV experiment, the velocity profiles on only one-half section of the vessel could 
be measured due to the shaft blocking the laser light sheet. In the standard system, only 
one lengthwise cross-section of the vessel was studies, since the standard system (without 
the cannula) was symmetrical.  In the system with the cannula, the velocity profiles were 
measured on four lengthwise cross-sections, 90° apart from each other, since this system 
was non-symmetrical because of the presence of the cannula in the medium. Using the 
tablet position numbering mentioned before (Figure 2.6 (a)), the four sections were 
named Section A, Section B, Section C and Section D, as shown in Figure 2.8. However, 
when studying Section A, the cannula could block the laser light sheet. Therefore, two 
additional PIV measurements were conducted in order to show the velocities on vertical 
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planes just before or just behind the cannula: Section A-Front was the vertical section 
where the laser sheet was just in front of the cannula (by about 2 mm) while Section A-
Back, where the laser sheet was just behind cannula (by about 2 mm), as shown in Figure 
2.8 and Figure 2.9. The PIV measurements were conducted three times for all sections, 
except the Section A-Front and Section A-Back.  
A PIV measurement consisted of taking a pairs of images at a time interval of 1 
ms. In each PIV test, 300 image pairs in total were captured by the CCD camera, at a 
time interval of 1000 ms between each pair. Then, image masks were defined and applied 
to all images to reject the impeller and shaft regions, and the obscured regions not 
illuminated by the laser and all external regions, in order to reduce the error in cross 
correlation.  Each image was divided in interrogation areas 16 pixels x 16 pixels. Cross-
correlation was employed on each interrogation areas in each image pair to determine the 
most likely velocity vector that best resulted in the first interrogation area being 
superimposed on the second. That velocity vector was taken to be the velocity projection 
of the fluid velocity on that vertical section. For each interrogation area, the final velocity 
vector on the vertical section was taken to be the statistical average of the 300 pairs 
image pairs. By applying this approach to each area the velocity profile on the entire 
section was obtained. The profile then went through moving-range validation and average 
filter to obtain the final velocity vector map for further analysis. (FlowMap PIV 
Installation & User’s guide, 2000) 
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Section A               Section B 
 
Section C              Section D 
Figure 2.8 Schematic of the sections (in grey) studied using PIV. 
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Section A-Front                                             Section A-Back 
Figure 2.8 Schematic of the sections (in grey) studied using PIV (Continued). 
 
Section A 
 
Section A-Front                                            Section A-Back 
Figure 2.9 Schematic of the top views in Section A, Section A-Front and Section A-
Back. 
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Figure 2.10 Eleven iso-surfaces chosen for PIV measurements. 
 
The liquid velocity at any point in the vessel has three components: radial 
velocity, acting in a direction perpendicular to the shaft of the impeller; axial velocity, 
acting in a direction parallel with the shaft; and tangential velocity, acting in a direction 
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tangent to a circular path around the shaft. In this 2-D PIV study, only the axial and radial 
velocities were investigated. 
To fully quantify the fluid flow in the dissolution vessel, eleven iso-surfaces at 
different vertical (z) positions were selected along the height of the vessel, as shown in 
Figure 2.10. The bottom of the vessel was taken as the iso-surface at z = 0 mm. Four iso-
surfaces were chosen below the impeller (z = 5 mm, 10 mm, 15 mm and 20 mm). Three 
were chosen in the impeller region: the bottom edge of the impeller, i.e., z = 25mm, the 
middle of the impeller, i.e., z = 35mm, and the top edge of the impeller, i.e., z = 44mm. 
Four were chosen above the impeller: z = 50 mm, z = 75 mm, z = 100 mm and z = 125 
mm. The average radial and axial velocities and standard deviation for each data point on 
each iso-surface were extracted, plotted and analyzed. 
In order to determine the reproducibility of the PIV measurement and to 
determine the suitability of the instrument to detect differences between velocities in the 
standard system and in the testing system, six identical experiments with the standard 
system alone were conducted. The average standard deviations in those three regions, i.e., 
below the impeller, around the impeller and above the impeller, were calculated and 
presented.  
Sums of squared deviations were calculated to compare the velocity profiles on 
the four sections of the testing system to those of the standard system.  
 
𝑆 =� (𝑈 − 𝑈0)2
𝑈𝑡𝑖𝑝
2  (2.7) 
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where U is the velocity of the testing system and U0 is the corresponding velocity of the 
standard system at the same point. By summing up all squared deviations in each of the 
three regions, i.e., below the impeller, around the impeller and above the impeller, as well 
as in the whole section, the hydrodynamic effect generated by the cannula could be 
identified and quantified. 
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CHAPTER 3  
RESULTS 
As mentioned in Chapter 2, the objective of this project was to quantify the 
hydrodynamic effects introduced by the presence of a cannula in a USP Dissolution 
Testing Apparatus 2 by the dissolution test and PIV measurement. The dissolution 
profiles obtained in the two systems (standard system and testing system) were compared 
by plotting mD/mT (fractional drug release) against time (min) and evaluating the 
difference using statistical tools. The velocity profiles obtained from the PIV 
measurements for the two systems were also compared by visualizing the flow velocity 
vectors and quantitatively analyzing the velocities on eleven iso-surfaces. 
3.1 Results of the Dissolution Tests 
In order to determine the effect of the cannula in dissolution tests, experimental data 
obtained from two systems, with and without cannula, were examined for all nine 
different tablet positions. The averages of triplicate experimental dissolution profiles at 
each tablet position are presented in terms of mD/mT against time together with the 
standard deviations of three replicates (Figure 3.2 through Figure 3.10). The results of the 
dissolution test following the USP procedure is shown in Figure 3.11. The difference 
factor (f1), similarity factor (f2) and probability associated with the Students’ t-test (P(t-
test)) were calculated for the averages of triplicate experimental profiles at each tablet 
position, and are presented in Table 3.2.  
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3.1.1 Calibration Results for Salicylic Acid Tablets 
Calibration was performed following the method described in Section 2.1.3. A series of 
salicylic acid solution with known concentration were detected by the UV 
spectrophotometer at the wavelength 296 nm. This process was initially performed twice 
to establish the conversion from UV absorbance to salicylic acid concentration, and 
repeated every 3 months, without showing significant change.  The results are presented 
in Table 3.1 and Figure 3.1 for two sets of calibration experiments. 
Table 3.1 Calibration Data for Prednisone Tablets 
Concentration 
(mg/ml) 
Absorbance 1 Absorbance 2 
Average 
Absorbance 
0.00000 0.036 0.036 0.036 
0.00234 0.090 0.092 0.091 
0.00469 0.145 0.145 0.145 
0.00938 0.252 0.253 0.2525 
0.01875 0.467 0.470 0.4685 
0.03750 0.895 0.899 0.897 
0.07500 1.711 1.717 1.714 
 
The difference between the two set of absorbance data was minor, and the R2 
value of the regression was 0.9998.  Therefore, a linear relation between UV absorbance 
and concentration was confirmed in this concentration range (0 – 0.075 mg/mL). The 
equation displayed in Figure 3.1 was used to obtain the sample concentration from 
absorbance data. 
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Figure 3.1 Calibration curve and regression for Salicylic Acid tablets. 
 
3.1.2 Dissolution Profiles for Centered Tablets (Position O) 
The dissolution profiles for the tablets in the center position are presented in Figure 3.2. 
This figure shows that the difference between the dissolution profiles for the testing 
system (with cannula) and the standard system (without cannula) is that at all times the 
average mass percentage of drug dissolved in the testing system was higher than in the 
standard system. Each individual paired experiment replicate also showed this difference 
(results are not shown here). The average standard deviations for the drug release mass 
ratios (mD/mT) in Figure 3.2 were 1.08% and 1.54% for the dissolution profiles with and 
without cannula, respectively. The value of paired Student’s t-test, i.e., the probability 
that the dissolution profiles came from the same population, was 0.000209 (Table 3.2), 
which was much lower than the significance level of 0.05.  On the other hand, the values 
of f1 factor and f2 factor, quantifying the significance of similarity/difference of two 
dissolution profiles, were 12.25, 86.17, respectively, which were both within the FDA 
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required range (0<f1<15 and 50<f2<100). Although the value of f1 factor (12.25) was not 
too distant from the upper limit f1 (15), those values were considered to be acceptable. 
Table 3.2.  Average Values of P(t-test), f1 and f2 for Dissolution Tests at Each Tablet 
Position  
Tablet Position P (t-test) f1 f2 
Centered O 0.000209 12.25 86.17 
10° off-center 
A1 0.000290 17.14 74.81 
B1 0.001038   3.03 96.93 
C1 0.000129 12.03 83.42 
D1 0.005908   4.37 92.97 
20° off-center 
A2 0.000313   6.81 88.72 
B2 0.002889   1.64 98.55 
C2 0.000042   1.42 99.16 
D2 0.021561   2.84 94.69 
Dropped Tablets (USP Procedure) 0.000082   6.87 90.89 
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Figure 3.2 Dissolution profiles for experiments with tablets in Position O in the presence 
and absence of the cannula. 
 
3.1.3 Dissolution Profiles for 10° Off-Center Tablets (Positions A1, B1, C1, and D1) 
The results for the tablet on the 10° off-center circle positions are shown in Figure 3.3 
through Figure 3.6, respectively, and the corresponding statistics are presented in Table 
3.2. The average standard deviations for the drug release mass ratios (mD/mT) on the 10° 
circle positions were 1.12% and 1.44% for the dissolution profiles in the two systems 
with and without cannula, respectively. The values of Student’s t-test were all much 
lower than the significant level 0.05 for all 10° off-center tablet positions.  
Compared to the dissolution profiles for tablets in the center of the vessel bottom 
(Position O), the drug release fractions (mD/mT) for tablets on this circle were always 
much higher. For example, at t = 45 min, mD/mT was typically about 27-33% for the 10° 
off-center tablets whereas it was only about 22-24% for the centered tablets. These results 
were in agreement with previously reported work (Wang and Armenante, 2012).   
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For all the four positions on 10° off-center circle, the tablets in the system with 
the cannula generated higher dissolution profiles than those in the standard system 
without cannula.  However, the intensities of the differences between the profiles from 
two systems were different depending on the tablet locations. The tablet position that 
produced the most different dissolution profiles on 10° circle was Position A1, which was 
the closest to the cannula.  The calculation of difference factor f1, similarity factor f2 and 
Student’s t-test confirmed this observation: f1 had the largest value of all tablets positions 
(17.14), f2 the smallest (74.81) and P(t-test) value was much less 0.05. In fact, Position 
A1 was the only case for which f1>15, resulting in a test failure.   
The next most significant difference between profiles was at Position C1.  Tablets 
in Position B1 and Position D1 were much lesser affected by the presence of the cannula, 
as indicated by the smaller value for f1 (3.03, 4.37) and larger value for f2 (96.93, 92.97) 
for this case compared to other tablet positions (Table 3.2).  However, the Student’s t-test 
value was still very small (0.001038, 0.005908) for Position B1 and Position D1, 
indicating that the two curves were still statistically different (P(t-test)<0.05). 
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Figure 3.3 Dissolution profiles for experiments with tablets in Position A1 in the 
presence and absence of the cannula.  
 
Figure 3.4 Dissolution profiles for experiments with tablets in Position C1 in the 
presence and absence of the cannula. 
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Figure 3.5 Dissolution profiles for experiments with tablets in Position D1 in the 
presence and absence of the cannula.  
 
Figure 3.6 Dissolution profiles for experiments with tablets in Position B1 in the 
presence and absence of the cannula.   
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3.1.4 Dissolution Profiles for 20° Off-Center Tablets (Positions A2, B2, C2, and D2) 
The results for the tablet on the 20° off-center circle positions are presented in Figure 3.7 
through Figure 3.10 and the corresponding statistics are shown in Table 3.2. The average 
standard deviations for drug release mass ratios (mD/mT) in these figures were 1.26% and 
1.27% for the dissolution profiles of the two systems with and without cannula, 
respectively. The differences between the profiles for the systems on the 20° off-center 
circle were less evident. In Position B2, Position C2 and Position D2 the mD/mT profiles 
for the testing system were nearly identical or even below those for the standard system. 
However, their values of t-test were still lower than the significance level of 0.05, 
indicating that the two profiles were still statistically different. Only for Position A2 the 
difference between the dissolution profiles for the two systems, was noticeable, although 
only to a limited extent. For all positions in the 20° off-center circle, the f1 and f2 values 
were in the appropriate range to pass the dissolution test, even for the Position A2 (f1 
=6.81, f2 =88.72). 
The dissolution profiles of tablets on the outer circle (20° off-center circle) were 
always higher comparing to those on the inner circle (10° off-center circle), as previously 
reported (Wang and Armenante, 2012). The results for tablets on two circles show some 
similarities. Tablets nearest to the cannula (Positions A1 and A2) produced higher 
differences between dissolution profiles with and without the cannula. However, in all 
cases, the effect of the cannula was more pronounced when the tablets were on the inner 
circle than when they were on the outer circle. 
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Figure 3.7 Dissolution profiles for experiments with tablets in Position A2 in the 
presence and absence of the cannula.     
 
Figure 3.8 Dissolution profiles for experiments with tablets in Position B2 in the 
presence and absence of the cannula.     
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Figure 3.9 Dissolution profiles for experiments with tablets in Position C2 in the 
presence and absence of the cannula.    
 
Figure 3.10 Dissolution profiles for experiments with tablets in Position D2 in the 
presence and absence of the cannula.    
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3.1.5 Dissolution Profiles for the Tablets using USP Dissolution Procedure 
According to the USP (2012), in the standard dissolution test the tablet is dropped into 
the vessel after the medium had been added to the vessel and heated to 37ºC.  The results 
for the tablets using the USP dissolution procedure are shown in Figure 3.11, and the 
corresponding statistics are shown in Table 3.2. The average standard deviations for the 
drug release mass ratios (mD/mT) were 0.36% and 1.04% for dissolution profiles in the 
standard system and the testing system, respectively. The dissolution profile obtained 
from the testing system was slightly higher than that obtained from the standard system. 
The value of the Student’s t-test (0.0000816) was much smaller than the significance 
level (0.05). The values of f1 and f2 factors were 6.87, 90.89 respectively, which were 
both within the FDA required range (0< f1 <15 and 50 < f2 <100). 
 
Figure 3.11 Dissolution profiles for experiments with tablets using USP Procedure in the 
presence and absence of the cannula. 
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3.2 Results of PIV Measurement 
3.2.1 Velocity Vectors 
The velocity vectors maps of the two systems are shown in Figure 3.12 and Figure 3.13. 
In order to shown the entire velocities vector in Section A, two other tests (Section A-
Front, i.e., the laser sheet was in front of the cannula, and Section A-Back, i.e., the laser 
was behind the cannula) were conducted and also presented in Figure 3.13. The vectors in 
each of the images were scaled according to their magnitudes using the same scale factor. 
The vectors were color-coded in order of increasing velocity magnitude. The vectors with 
the lowest velocities were plotted in dark blue, followed by light blue, green, yellow, 
orange and red, which represented the highest velocities.  
The overall flow patterns that emerged from the vector maps were found to be 
similar, as shown in Figure 3.12 and Figure 3.13. A big but weak recirculation loop 
dominated by the axial velocity component generated by the impeller rotation can be 
observed in the upper region of the vessel. Near the vessel wall (R/R0> ~0.7) this flow 
was directed upwards, while in the middle inner core region above the impeller (~0.3 < 
R/R0< ~0.7), the flow was directed downwards.  In the innermost core region (R/R0< 
~0.3), the flow is characterized by very low axial and radial velocities. The fluid region 
around the impeller was dominated by the impeller rotation (Bai et al., 2007). The axial 
and radial velocities changed significantly in this region. The flow in the region below 
the impeller is the most important and complex for this work. All test sections show that 
the flow in this region was very weak, especially the inner region just below the shaft at 
the center of the vessel bottom. In this region, there was another recirculation loop 
formed by the downwards flow produced by the agitation of the impeller and the vessel 
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wall. This vertical recirculation loop was not able to penetrate the weak inner core region. 
The flow patterns in the standard system are in agreement with those obtained in previous 
studies (Bai et. al., 2007, Bai et al., 2009). 
Despite the similarity between figures, two major differences could be observed. 
Firstly, in almost all sections in the system with the cannula the recirculation loop above 
the impeller became more intense, especially in the middle inner core region. The most 
significant effect was on Section A (Back), followed by Section B and Section C, and this 
effect seemed to disappear in Section D.  This makes intuitive sense, in that the intensity 
of the disturbances introduced by the cannula extends downstream of the cannula but 
with decreasing intensity.  Secondly, the velocities below the shaft, which is the most 
important region in the vessel since this is where the tablets usually stay in practice, were 
slightly stronger in Section A, Section A-Front and Section A-Back than in any other 
sections, where larger radial velocities could be found especially near the center of the 
vessel bottom. By contrast, in Section B, Section C and Section D, the velocities 
remained nearly the same as those in the standard system, or even slightly smaller.  
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Figure 3.12 PIV velocity vectors map for the standard system (velocities are in m/s). 
   
                              Section A                         Section A-Front                Section A-Back 
Figure 3.13 PIV velocity vectors maps for all four sections in the testing system with 
cannula (velocities are in m/s). 
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                                Section B                             Section C                           Section D 
Figure 3.13 PIV velocity vectors maps for all four sections in the testing system with 
cannula (velocities are in m/s) (Continued). 
 
3.2.2 Velocity Profiles on Iso-Surfaces 
Figures 3.14 through 3.19 show, respectively, the radial and axial velocity profiles on 
eleven iso-surfaces. In these figures, the ordinates represent the normalized fluid velocity 
U/Utip (scaled by the impeller tip speed, Utip=0.388 m/s) and the abscissas represent the 
normalized radial position R/R0 (scaled using the vessel radius, R0=50.08 mm). The 
centrifugal radial velocity and the upwards axial velocity were defined as positive 
velocities. It should be remarked that the scales in these figures are different. 
3.2.2.1 Reproducibility of PIV Measurements. The average standard deviations in the 
three regions examined here, i.e., below the impeller, around the impeller and above the 
impeller, are presented in Table 3.3. The PIV measurements were found to be very 
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reproducible in the regions below and above the impeller, while a slightly larger standard 
deviation was found for the velocities around the impeller, because the velocities in this 
region were affected by the presence of the impeller.  Therefore, these velocities were 
larger and more turbulent, causing more variability in the velocity data. 
Table 3.3 Average Standard Deviations of PIV Measurements in Three Regions for the 
Standard System 
Region Iso-Surfaces Average Standard Deviation 
Below the Impeller Z=5 mm, 10 mm, 15 mm, 20 mm 0.003890 
Around the Impeller Z=44 mm, 35 mm, 25 mm 0.006907 
Above the Impeller Z=50 mm, 75 mm, 100 mm, 125 mm 0.003111 
Overall Average 0.004429 
 
3.2.2.2 Velocity Profiles below the Impeller. Figure 3.14 and 3.15 show, respectively, 
the average radial and axial velocity profiles and the standard deviation for each data 
point on iso-surfaces below the impeller, i.e., Z=5 mm, 10 mm, 15 mm and 20 mm. 
In general, the differences between the velocities in this region were small in 
absolute value.  The largest differences in radial velocities were found in the weak 
velocity zone blow the shaft, i.e., R/R0< 0.2 for all four iso-surfaces. The most significant 
velocity differences were found in Section A. Slightly higher axial velocities in Section A 
were also observed in a smaller zone below the shaft, i.e., R/R0<0.1 for all four iso-
surfaces. This is consistent with velocity vector maps in Section 3.2.1.  
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Figure 3.14 PIV measurements for radial velocities on different iso-surfaces below the 
impeller. 
 
-0.1
-0.05
0
0.05
0.1
0 0.2 0.4 0.6 0.8 1U
ra
da
l/U
tip
 
R/R0 
Z = 5 mm 
Standard Section A Section B Section C Section D
-0.1
-0.05
0
0.05
0.1
0 0.2 0.4 0.6 0.8 1U
ra
da
l/U
tip
 
R/R0 
Z = 10 mm 
Standard Section A Section B Section C Section D
-0.1
-0.05
0
0.05
0.1
0 0.2 0.4 0.6 0.8 1U
ra
da
l/U
tip
 
R/R0 
Z = 15 mm 
Standard Section A Section B Section C Section D
 47 
 
Figure 3.14 PIV measurements for radial velocities on different iso-surfaces below the 
impeller (Continued). 
 
 
 
Figure 3.15  PIV measurements for axial velocities on different iso-surfaces below the 
impeller. 
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Figure 3.15  PIV measurements for axial velocities on different iso-surfaces below the 
impeller (Continued). 
 
3.2.2.3 Velocity Profiles around the Impeller. Figure 3.16 and 3.17 show, respectively, 
the average radial and axial velocity profiles and standard deviation for each data point 
on the iso-surfaces around the impeller, i.e., Z=25 mm, 35 mm and 44 mm. 
As shown in these figures, a larger average standard deviation in this region was 
obtained, which was agreement with the results of reproducibility for standard system in 
this region (Table 3.3). Although the differences between each section were found much 
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several differences cannot be attributed to experimental error. On iso-surface Z=35 mm, 
where the transition between two recirculation loop occurred, all sections showed 
different flow velocities compared to the standard system, indicating that the flows were 
stronger in this zone. On iso-surface Z=44 mm, the radial velocity in Section A was much 
higher than for other sections in the zone near the impeller (~0.7<R/R0<~ 0.8).  
 
 
Figure 3.16 PIV measurements for radial velocities on different iso-surfaces around the 
impeller. 
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Figure 3.16 PIV measurements for radial velocities on different iso-surfaces around the 
impeller (Continued). 
 
 
 
Figure 3.17 PIV measurements for axial velocities on different iso-surfaces around the 
impeller. 
-0.1
-0.05
0
0.05
0.1
0 0.2 0.4 0.6 0.8 1U
ra
da
l/U
tip
 
R/R0 
Z = 44 mm 
Standard Section A Section B Section C Section D
-0.1
-0.05
0
0.05
0.1
0 0.2 0.4 0.6 0.8 1U
ax
ia
l/U
tip
 
R/R0 
Z = 25 mm 
Standard Section A Section B Section C Section D
-0.1
-0.05
0
0.05
0.1
0 0.2 0.4 0.6 0.8 1U
ax
ia
l/U
tip
 
R/R0 
Z = 35 mm 
Standard Section A Section B Section C Section D
 51 
 
Figure 3.17 PIV measurements for axial velocities on different iso-surfaces around the 
impeller (Continued). 
 
3.2.2.4 Velocity Profiles above the Impeller. Figure 3.18 and 3.19 show, respectively, 
the average radial and axial velocity profiles and standard deviation for each data point 
on the iso-surfaces above the impeller, i.e., Z=50 mm, 75 mm, 100 mm, and 125 mm. In 
section A, just part of the velocity profiles were shown in the figures, since the laser sheet 
was blocked by the cannula. The differences in velocities profiles between different 
systems can be easily observed in this region, specifically, in the area where the cannula 
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~0.3< R/R0<~0.5. In the region where ~0.7<R/R0<~0.8, the radial velocities in Section A 
were much higher than those in other sections on all iso-surfaces. The largest differences 
in axial velocities were in the region ~0.3< R/R0<~0.5 where all the testing sections 
produced velocity profiles higher than those in in standard system.  Overall, in Section A 
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Figure 3.18 PIV measurements for radial velocities on different iso-surfaces around the 
impeller. 
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Figure 3.18 PIV measurements for radial velocities on different iso-surfaces around the 
impeller (Continued). 
 
 
 
Figure 3.19 PIV measurements for axial velocities on different iso-surfaces around the 
impeller. 
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Figure 3.19 PIV measurements for axial velocities on different iso-surfaces around the 
impeller (Continued). 
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deviations and much higher than Section D.  The velocities around the impeller didn’t 
show the significant effect on the presence of the cannula, considering the highest 
standard deviation (0.006907) in all three regions in the reproducibility test. Section A 
also was where largest difference can be found in the region below the impeller. In this 
region, Section B, Section C and Section D produced similar but a lower S value, 
indicating the effect of cannula was not significant in these sections. 
Table 3.4 Sums of Squared Deviations  
Section Section A Section B Section C Section D 
Below the Impeller 0.007977 0.002676 0.002578 0.002769 
Around the Impeller 0.005403 0.003755 0.005377 0.001062 
Above the Impeller 0.015841 0.012758 0.014871 0.006614 
Total 0.029221 0.019189 0.022826 0.010445 
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CHAPTER 4  
DISCUSSION 
4.1 Dissolution Tests 
In this work, the results of the dissolution experiments show that the dissolution profiles 
for the systems with cannulas tend to be higher than those in the standard systems, 
without cannulas irrespective of tablet position, with the exception of the tablet Position 
D2. These differences were slightly but observable from the averages of triplicated paired 
dissolution profiles (as reported in Figure 3.2 through Figure 3.10, with the exception of 
Figure 3.10), and ranged from 4.5% to 0.2%, depending on tablet location. Most 
differences between the dissolution profiles might not be attributed to data scatter since 
the average standard deviation of triplicate experiments was usually small (the standard 
system 1.38% and the testing system 1.18%). The Student’s t-test values for all runs were 
lower than the 0.05 significance level by one or more orders of magnitudes, indicating 
that the systems with and without the cannula generated statistically different dissolution 
profiles, i.e., that the results obtained with the two systems were unlikely to come from 
the some population. 
On the other hand, the difference factor f1 and similarity factor f2 for most runs 
were within the FDA required ranges, i.e., 0<f1<15 and 50<f2<100, indicating that the 
differences introduced by the permanently inserted cannula, although clearly measurable, 
were not typically significant enough to fail the dissolution test (although the f1 test for 
Position A1 failed). However, the enhancing effect of the presence of the cannula on the 
dissolution rate would reduce the tolerance limit of the dissolution test and make the 
system with cannula permanently inserted more likely to fail the test. For example, a 
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tablet that would intrinsically dissolved slightly faster but still within the dissolution 
testing acceptance range if measured in a standard system, could possibly produce an out-
of-range dissolution profile and fail the test due to the presence of the permanently 
inserted cannula enhancing the dissolution rate. Therefore, dissolution test developers 
should consider developing baseline dissolution profiles with the cannula always inserted 
in order to reduce the impact that any hydrodynamic changes associated with the 
presence of the cannula can introduce. 
The effect of the presence of the cannula could be observed for both centered and 
off-center tablet locations (Table 3.2). On average, this impact was more significant for 
tablet closer to the center position. It is important to emphasize the dissolution profiles 
for centered tablets were appreciably affected by the presence of the cannula (Figure 3.2), 
and this is important in practice because this is the most likely tablet location in most 
practical situations. For tablets in the 10° off-center positions, the cannula effect was 
even more significant, but only for tablets positioned the nearest to the cannula (Position 
A1; Figure 3.3). For the tablets in the 20° off-center positions, a similar but reduced trend 
was observed by comparing the dissolution profiles for tablets at the same azimuthal 
location nearest to the cannula but at different off-center displacements, i.e., Position A1 
(on the 10° circle; Figure 3.3) vs. Position A2 ( on the 20° circle; Figure 3.7). 
The reasons for such a small geometric change (the cannula OD was only 3.14 
mm and the length immersed in the medium was 44.22 mm) could produce an 
appreciable effect on dissolution can be attributed to two different but related 
phenomena.  The first is the presence of a small “baffle” introduced by the inserted 
cannula in the dissolution system. As a small symmetrical unbaffled system, the standard 
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USP Apparatus 2 generates a tangential flow with very limited velocity components in 
vertical and radial directions around the impeller and the shaft (Bai and Armenante, 2008; 
Bai et al., 2011, 2007; Baxter et al., 2005).  The tangential flow would be partially 
affected by the cannula, just like any small baffle. A slightly stronger top-to-bottom 
recirculation could be produced in the system, resulting in the enhanced dissolution rate 
of the tables. This is not surprising because a number of mixing literature (Akiti et al., 
2005; Armenante et al., 2005; Atiemo-Obeng et al., 2004) documents the effect of the 
introduction of baffles, even small baffles, on mixing. 
The second effect is a small asymmetry introduced by the cannula inserted on one 
side of an otherwise symmetrical USP Apparatus 2 system. As a perfectly symmetrical 
system, Apparatus 2 can be expected to be very sensitive to any deviation from 
symmetry, such as the presence of the cannula. In general, asymmetric systems generate a 
non-symmetrical three-dimensional flow to enhance mixing effects. Loss of symmetry 
can result from a number of geometric irregularities and operating irregularities (Scott, 
2005), such as a slightly geometry changes of the vessel (Tanaka et al., 2005; Liddell et 
al., 2007), small displacement of the impeller location or even the off-center location of 
the tablet (Bai and Armenante, 2009).  In most cases, changes in the dissolution profiles 
even test failures have typically been reported for these systems. 
The combined effects (baffle effect and asymmetry effect) can be especially 
important for the flow in the region below the impeller where the tablets are always 
located. Usually the flow in this zone is especially week and can be easily perturbed by 
even small changes in the system. When this happens, a tablet located in the same region 
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can experience a relative but appreciably more intense flow around it, thus resulting in a 
relative higher dissolution rate, as observed here for most tablet locations.  
The tests conducted using the USP procedure, i.e., the dropping of the tablet in the 
vessel at the beginning of the test, confirmed that the cannula had an effect on 
dissolution.  The dissolution profiles in the testing system were slightly higher than those 
in standard system not only when the average of three runs were considered, but also in 
each individual run. 
As mentioned before, the cannula had a stronger effect on the 10° off-center 
locations than on the 20° positions by comparing the tablet position in the same 
azimuthal direction but on the different circles. The tablets on the center position were 
significantly affected. This implies that the hydrodynamic effect of the cannula is 
different depending on the tablet positions, and it is more pronounced when the tablets 
are closer to the center of the vessel bottom and in the zone where the cannula was 
located (Position A1 and Position A2). 
4.2 PIV Measurements 
The results of the PIV measurements were consistent with the results from experimental 
dissolution tests, and showed that the hydrodynamics in the dissolution vessel was 
slightly affected by the introduction of the cannula.  
The general, the overall flow pattern in the dissolution vessel was similar in all 
four sections in the testing system, according to the velocity vector maps (Figure 3.12 and 
Figure 3.13). The main features of this flow consisted of two recirculation loops, below 
and above the impeller, and a very weak-velocity region below the shaft. On the other 
hand, when the cannula was inserted a significant flow perturbation was observed above 
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the impeller, and not only on Section A, i.e., in proximity of the cannula, but also in 
Section B and Section C. This confirmed that the cannula produce a “baffle effect” 
altering the fluid flow in the vessel. This effect decreased downstream of the cannula and 
was minor on Section D, the most downstream section with respect to the cannula 
location.  The effect of the cannula could be even better noticed by comparing the 
velocities on Section A-Front and Section A-Back. The velocity increase in this region is 
ultimately responsible for the change in velocities in the lower portion of the vessel and 
the resulting increase in the dissolution rate of the tablets fixed in those positions, since 
tablets would directly experience the flow in this region. 
Further quantitative study on the eleven iso-surfaces selected showed in detail the 
differences in the radial velocity profiles and axial velocity profiles between the standard 
system and the testing system, and between different sections in the testing system 
(Figures 3.14 through 3.19).  
In the region above the impeller, the most significant difference was observed in 
Section A, and this was in agreement with the observation from the velocity vector maps. 
The S values in this region showed the results of the “baffle effect” and the largest S 
value was found in Section A. The cannula disturbed the flow in this section and 
generated the largest deviation in Section A, and then this flow perturbation extended 
downstream through Section B, Section C and became much weaker when passing 
through Section D. Much smaller S values were found in Section D, which was in 
agreement with the vector velocity map of Section D.  
In the region around the impeller, despite the largest variation in the 
reproducibility test due to more turbulent flows (Table 3.3), the S values were relative 
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uniform in all four sections (Table 3.4), indicating that the introduction of the cannula did 
not significantly affect flows in this region, which remained dominated by the impeller. 
The region below the impeller was more carefully studied and four iso-surfaces 
were selected here (i.e., Z=5 mm, 10 mm, 15 mm and 20 mm), since the dissolution rate 
of the tablet was expected to be more sensitive to the flow velocity it experienced directly 
in this region. Section A was found to have the largest S value of all the sections, which 
coincided with the faster dissolution rates of tablets in Position A1 and Position A2. This 
can be explained that the perturbation generated by the cannula above the impeller which 
reached the region below the impeller at a location nearest to the cannula. Although the 
perturbation may die down along the recirculation pattern, its effect could still be noticed, 
especially considering the low velocities baseline below the shaft. This also explained 
why the effect was more pronounced for tablets placed 10° off-center circle positions 
than 20° off-center circle. The tablet positions in the center and 10° circle were within or 
partially within the low velocity region under the impeller, while the 20° circle positions 
were within the upwards recirculation region. Therefore, the baseline velocities were 
much lower in central and 10° circle positions. As a result, any velocity perturbation in 
this region was more significant, and greater differences in dissolution rates between the 
two systems were observed for these tablet positions. 
 62 
CHAPTER 5  
CONCLUSIONS 
The hydrodynamic effects of a cannula in USP Dissolution Testing Apparatus 2 were 
determined by experimentally comparing the dissolution profiles obtained in the testing 
system with those in the standard system, and by determining the flow velocities in the 
two systems via PIV.  
Several conclusions can be drawn from this study. The cannula  inserted in the 
USP-specified sampling zone in the USP Apparatus 2 resulted in dissolution profiles for 
non-disintegrating salicylic acid tablets located at different positions on the vessel bottom 
that were statistically different from the corresponding dissolution profiles obtained in the 
absence of the cannula, as indicated by the result of a paired t-test (P(t-test)<0.05). These 
differences were reproducible and systematic: in nearly all cases, the presence of the 
cannula resulted in faster dissolution rates.  
The magnitude of the difference between dissolution profiles depended on tablet 
location: larger differences were observed with tablets located closer to the cannula. 
These effects can be attributed to the changes in hydrodynamics introduced by the 
presence of the cannula, and mainly to the partial to the partial baffling effects and the 
loss of symmetry caused by the insertion of the cannula.  
The PIV measurements showed that the cannula did have a baffling effect on the 
hydrodynamics in the dissolution vessel. This effect resulted in slightly changes in the 
velocities in the vessel, and therefore in slightly larger differences in the dissolution rate 
of the testing tablets. The baffling effect was clearly observed in the region where the 
cannula was inserted. The flow perturbation that it generated became gradually weaker 
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downstream of the agitation path. This perturbation was also found to reach the region 
below the impeller but only the section nearest to the cannula had significant higher fluid 
velocities. Additionally, the PIV results showed that the baffle effect was not strong 
enough to break the overall flow pattern, or to affect the region around the impeller, 
which was dominated by the agitation flow.  
In summary, the hydrodynamic effects generated by the cannula are real and 
observable, resulting in slightly modification of the fluid flow in the dissolution vessel 
and therefore in detectable differences in the dissolution profiles. Although the 
differences between the dissolution profiles in two systems were generally small enough 
for the dissolution profiles to be considered acceptable using the FDA criteria (f1 and f2 
values), the enhanced dissolution rate caused by the cannula could reduce the tolerance 
limit of the dissolution test and make tablets tested in systems with a cannula 
permanently inserted more likely to fail the test. Therefore, it is recommended that 
dissolution test developers who plan to conduct manual sampling with the cannula 
inserted permanently should develop baseline dissolution profiles with a cannula always 
inserted, in order to reduce the impact that any hydrodynamic changes associated with the 
presence of the cannula can introduce. 
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